Millennium Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Buy
1,005,458
+622,321
+162% +$17.5M 0.01% 1355
2025
Q4
$12.1M Buy
383,137
+278,077
+265% +$9.22M 0.01% 2063
2025
Q3
$3.75M Sell
105,060
-85,232
-45% -$3.89M ﹤0.01% 3434
2025
Q2
$11M Sell
190,292
-352,695
-65% -$19.9M 0.01% 2168
2025
Q1
$31.6M Buy
542,987
+255,140
+89% +$17.4M 0.02% 1116
2024
Q4
$23.2M Buy
287,847
+233,241
+427% +$19.9M 0.01% 1394
2024
Q3
$4.38M Sell
54,606
-38,086
-41% -$2.71M ﹤0.01% 2955
2024
Q2
$5.66M Buy
92,692
+39,201
+73% +$2.33M ﹤0.01% 2612
2024
Q1
$2.64M Buy
+53,491
New +$2.55M ﹤0.01% 3482
2023
Q3
Sell
-318,348
Closed -$10.9M 6458
2023
Q2
$11.3M Buy
318,348
+205,232
+181% +$6.79M 0.01% 1904
2023
Q1
$3.21M Sell
113,116
-350,540
-76% -$12.4M ﹤0.01% 2995
2022
Q4
$19.3M Buy
463,656
+255,715
+123% +$11M 0.01% 1481
2022
Q3
$8.62M Buy
+207,941
New +$8.29M 0.01% 2324
2022
Q1
Sell
-85,247
Closed -$2.13M 7364
2021
Q4
$2.13M Buy
85,247
+40,724
+91% +$1.51M ﹤0.01% 3717
2021
Q3
$1.7M Buy
+44,523
New +$1.71M ﹤0.01% 4103

Other funds holding PRCT

Millennium Management's PRCT Position: Q1 2026 in Review

Millennium Management increased its Procept Biorobotics (PRCT) stake by 162% in Q1 2026, buying an estimated $17.5M and bringing the position to 1,005,458 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #1355.

Millennium Management first reported a position in PRCT in Q3 2021 and has held it in 15 quarters since. The position peaked at $31.6M in Q1 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Millennium Management held 1,005,458 shares of Procept Biorobotics worth $25.1M as of Q1 2026.
  • Millennium Management bought 622,321 Procept Biorobotics shares in Q1 2026, an estimated $17.5M.
  • Procept Biorobotics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1355 holding.
  • Millennium Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 15 quarters since.
  • Millennium Management's Procept Biorobotics position peaked at $31.6M in Q1 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.